AAAAAA

   
Results: 1-25 | 26-32
Results: 1-25/32
CYTOKINE-MEDIATED APOPTOSIS AND INHIBITION OF VIRUS PRODUCTION AND ANCHORAGE-INDEPENDENT GROWTH OF VIRAL TRANSFECTED HEPATOBLASTOMA CELLS
Authors: YARED G HUSSAIN KB NATHANI MG MOSHIER JA DOSESCU J MUTCHNICK MG NAYLOR PH
Citation: G. Yared et al., CYTOKINE-MEDIATED APOPTOSIS AND INHIBITION OF VIRUS PRODUCTION AND ANCHORAGE-INDEPENDENT GROWTH OF VIRAL TRANSFECTED HEPATOBLASTOMA CELLS, Cytokine (Philadelphia, Pa. Print), 10(8), 1998, pp. 586-595
CLINICAL CORRELATES OF HISTOLOGIC GRADE AND STAGE IN HEPATITIS-C VIRUS (HCV) INFECTION
Authors: BENTLEY G NATHANI MG VANDERHEIDE RS MUTCHNICK MG TURNER JR
Citation: G. Bentley et al., CLINICAL CORRELATES OF HISTOLOGIC GRADE AND STAGE IN HEPATITIS-C VIRUS (HCV) INFECTION, Modern pathology, 11(1), 1998, pp. 151-151
VIRAL LOAD, AGE, RACE, GENDER AND SERUM TRANSAMINASE LEVELS PREDICT HISTOLOGICAL GRADE AND STAGE IN HEPATITIS-C VIRUS (HCV) INFECTION
Authors: SHAHZAD S BENTLEY G NATHANI MG NAYLOR PH EHRINPREIS MN PELEMAN PR KINZIE JL MUTCHNICK MG TURNER JR
Citation: S. Shahzad et al., VIRAL LOAD, AGE, RACE, GENDER AND SERUM TRANSAMINASE LEVELS PREDICT HISTOLOGICAL GRADE AND STAGE IN HEPATITIS-C VIRUS (HCV) INFECTION, Hepatology, 28(4), 1998, pp. 154-154
RACE, HEPATITIS-C GENOTYPE AND ALT-GREATER-THAN-AST PREDICT THE PROBABILITY OF RESPONSE TO INTERFERON IN AN URBAN CLINIC POPULATION OF PATIENTS WITH CHRONIC HEPATITIS-C
Authors: EHRINPREIS MN NATHANI MG NAYLOR PH PETEMAN RR KINZIE JL LYBIK M MUTCHNICK MG
Citation: Mn. Ehrinpreis et al., RACE, HEPATITIS-C GENOTYPE AND ALT-GREATER-THAN-AST PREDICT THE PROBABILITY OF RESPONSE TO INTERFERON IN AN URBAN CLINIC POPULATION OF PATIENTS WITH CHRONIC HEPATITIS-C, Hepatology, 28(4), 1998, pp. 168-168
SERUM HCV RNA LEVELS AS DETERMINANTS FOR DOSE-ESCALATION OF INTERFERON - RESULTS FROM STUDIES IN AN URBAN CLINIC POPULATION
Authors: PELEMAN RR NAYLOR PH EHRINPREIS MN NATHANI MG KINZIE JL LYBIK M SIDDIQUI F MUTCHNICK MG
Citation: Rr. Peleman et al., SERUM HCV RNA LEVELS AS DETERMINANTS FOR DOSE-ESCALATION OF INTERFERON - RESULTS FROM STUDIES IN AN URBAN CLINIC POPULATION, Hepatology, 28(4), 1998, pp. 830-830
3 NEGATIVE PCR FOR HCV RNA AT INTERVALS OF ONE MONTH ARE NOT ADEQUATETO PREDICT A SUSTAINED RESPONSE TO INTERFERON
Authors: NATHANI MG NAYLOR PH EHRINPREIS MN KINZIE JL LYBIK M PELEMAN RR MUTCHNICK MG
Citation: Mg. Nathani et al., 3 NEGATIVE PCR FOR HCV RNA AT INTERVALS OF ONE MONTH ARE NOT ADEQUATETO PREDICT A SUSTAINED RESPONSE TO INTERFERON, Hepatology, 28(4), 1998, pp. 2158-2158
THE DEMOGRAPHIC-ANALYSIS OF CHRONIC HEPATITIS-C PATIENTS WITHIN A METROPOLITAN COMMUNITY PRACTICE
Authors: NATHANI MG EHRINPREIS MN NAYLOR PH LYBIK MJ PELEMAN RR KINZIE JL MUTCHNICK MG
Citation: Mg. Nathani et al., THE DEMOGRAPHIC-ANALYSIS OF CHRONIC HEPATITIS-C PATIENTS WITHIN A METROPOLITAN COMMUNITY PRACTICE, Gastroenterology, 114(4), 1998, pp. 460-460
AN UNUSUAL CASE OF AMOXICILLIN-CLAVULANIC ACID-RELATED HEPATOTOXICITY
Authors: NATHANI MG MUTCHNICK MG TYNES DJ EHRINPREIS MN
Citation: Mg. Nathani et al., AN UNUSUAL CASE OF AMOXICILLIN-CLAVULANIC ACID-RELATED HEPATOTOXICITY, The American journal of gastroenterology, 93(8), 1998, pp. 1363-1365
VARIATIONS IN SERUM HBV DNA LEVELS MEASURED BY 3 METHODOLOGIES IN PATIENTS WITH CHRONIC HEPATITIS-B (CHB)
Authors: NAYLOR PH DEMEDINA M NATHANI MG SIDDIQUI F SKUNCA M SCHIFF E LINDSAY K MUTCHNICK MG
Citation: Ph. Naylor et al., VARIATIONS IN SERUM HBV DNA LEVELS MEASURED BY 3 METHODOLOGIES IN PATIENTS WITH CHRONIC HEPATITIS-B (CHB), Hepatology, 26(4), 1997, pp. 756-756
COMBINATION LOW-DOSE LYMPHOBLASTOID INTERFERON AND THYMOSIN ALPHA(1) THERAPY IN THE TREATMENT OF CHRONIC HEPATITIS-B
Authors: RASI G MUTCHNICK MG DIVIRGILIO D SINIBALDIVALLEBONA P PIERIMARCHI P COLELLA F FAVALLI C GARACI E
Citation: G. Rasi et al., COMBINATION LOW-DOSE LYMPHOBLASTOID INTERFERON AND THYMOSIN ALPHA(1) THERAPY IN THE TREATMENT OF CHRONIC HEPATITIS-B, Journal of viral hepatitis, 3(4), 1996, pp. 191-196
THYMOSIN ALPHA-1 ASSOCIATED CLEARANCE OF SERUM HBV DNA OCCURS IN PATIENTS WITH CHRONIC HEPATITIS-B (CHB) WHO HAVE DNA LEVELS LESS-THAN-2500PG ML AND IS ACCOMPANIED BY A FLARE IN SERUM ALT/
Authors: NAYLOR PH NATHANI MG MUTCHNICK MG
Citation: Ph. Naylor et al., THYMOSIN ALPHA-1 ASSOCIATED CLEARANCE OF SERUM HBV DNA OCCURS IN PATIENTS WITH CHRONIC HEPATITIS-B (CHB) WHO HAVE DNA LEVELS LESS-THAN-2500PG ML AND IS ACCOMPANIED BY A FLARE IN SERUM ALT/, The FASEB journal, 10(6), 1996, pp. 33-33
TNF-ALPHA-S PLEOTROPIC ACTIVITY ON HEPATOBLASTOMA CELLS VARIES WITH THE ASSAY AND THE VIRAL TRANSFECTION OF THE CELLS
Authors: NAYLOR PH REDDY S SABIR T DOSESCU J MUTCHNICK MG MOSHIER JA
Citation: Ph. Naylor et al., TNF-ALPHA-S PLEOTROPIC ACTIVITY ON HEPATOBLASTOMA CELLS VARIES WITH THE ASSAY AND THE VIRAL TRANSFECTION OF THE CELLS, The FASEB journal, 10(3), 1996, pp. 2442-2442
TNF-ALPHA LEVELS IN SERA FROM PATIENTS WITH CHRONIC VIRAL-HEPATITIS ARE DEPENDENT ON THE ASSAY EMPLOYED
Authors: NATHANI MG MUTCHNICK MG NAYLOR PH
Citation: Mg. Nathani et al., TNF-ALPHA LEVELS IN SERA FROM PATIENTS WITH CHRONIC VIRAL-HEPATITIS ARE DEPENDENT ON THE ASSAY EMPLOYED, Hepatology, 24(4), 1996, pp. 1706-1706
THYMUS-DERIVED PEPTIDES IN THE TREATMENT OF VIRAL CHRONIC HEPATITIS
Authors: NAYLOR PH MUTCHNICK MG
Citation: Ph. Naylor et Mg. Mutchnick, THYMUS-DERIVED PEPTIDES IN THE TREATMENT OF VIRAL CHRONIC HEPATITIS, Digestive diseases, 14(6), 1996, pp. 362-370
THYMOSIN ALPHA-1 DOES NOT PROMOTE GROWTH OR ONCOGENIC TRANSFORMATION
Authors: NAYLOR PH SMITH MR MUTCHNICK MG NAYLOR CW DOSESCU J SKUNCA M MOSHIER JA
Citation: Ph. Naylor et al., THYMOSIN ALPHA-1 DOES NOT PROMOTE GROWTH OR ONCOGENIC TRANSFORMATION, International journal of immunopharmacology, 18(5), 1996, pp. 321-327
THYMOSIN-ALPHA(1), BUT NOT INTERFERON-ALPHA, SPECIFICALLY INHIBITS ANCHORAGE-INDEPENDENT GROWTH OF HEPATITIS-B VIRAL TRANSFECTED HEPG2 CELLS
Authors: MOSHIER JA MUTCHNICK MG DOSESCU J HOLTZ TK AKKARY S MAHAKALA K MERLINE JR NAYLOR PH
Citation: Ja. Moshier et al., THYMOSIN-ALPHA(1), BUT NOT INTERFERON-ALPHA, SPECIFICALLY INHIBITS ANCHORAGE-INDEPENDENT GROWTH OF HEPATITIS-B VIRAL TRANSFECTED HEPG2 CELLS, Journal of hepatology, 25(6), 1996, pp. 814-820
COMBINATION THYMOSIN ALPHA(1) AND LYMPHOBLASTOID INTERFERON TREATMENTIN CHRONIC HEPATITIS-C
Authors: RASI G DIVIRGILIO D MUTCHNICK MG COLELLA F SINIBALDIVALLEBONA P PIERIMARCHI P VALLI B GARACI E
Citation: G. Rasi et al., COMBINATION THYMOSIN ALPHA(1) AND LYMPHOBLASTOID INTERFERON TREATMENTIN CHRONIC HEPATITIS-C, Gut, 39(5), 1996, pp. 679-683
COMPARISON OF 2 HBV-DNA HYBRIDIZATION ASSAYS OF SERA FROM PATIENTS COMPLETING A CLINICAL-TRIAL OF THYMOSIN ALPHA(1) (T-ALPHA(1)) IN CHRONICHEPATITIS-B (CHB)
Authors: NAYLOR PH NATHANI M PELEMAN R EHRINPREIS MN MUTCHNICK MG
Citation: Ph. Naylor et al., COMPARISON OF 2 HBV-DNA HYBRIDIZATION ASSAYS OF SERA FROM PATIENTS COMPLETING A CLINICAL-TRIAL OF THYMOSIN ALPHA(1) (T-ALPHA(1)) IN CHRONICHEPATITIS-B (CHB), Gastroenterology, 110(4), 1996, pp. 1276-1276
APOPTOSIS AND CLONAL GROWTH-INHIBITION OF HBV- AND SV40 VIRUS TRANSFECTED HEPATOMA-CELLS BY INTERFERON-ALPHA AND TUMOR-NECROSIS-FACTOR-ALPHA
Authors: NAYLOR PH MOSHIER JM YARED G DOSESCU J NATHANI MG REDDY S HUSSAIN K MUTCHNICK MG
Citation: Ph. Naylor et al., APOPTOSIS AND CLONAL GROWTH-INHIBITION OF HBV- AND SV40 VIRUS TRANSFECTED HEPATOMA-CELLS BY INTERFERON-ALPHA AND TUMOR-NECROSIS-FACTOR-ALPHA, Hepatology, 22(4), 1995, pp. 1425-1425
THYMOSIN-ALPHA-1 TREATMENT OF CHRONIC HEPATITIS-B - A MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED DOUBLE-BLIND-STUDY
Authors: MUTCHNICK MG LINDSAY KL SCHIFF ER CUMMINGS GD APPELMAN HD
Citation: Mg. Mutchnick et al., THYMOSIN-ALPHA-1 TREATMENT OF CHRONIC HEPATITIS-B - A MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED DOUBLE-BLIND-STUDY, Gastroenterology, 108(4), 1995, pp. 1127-1127
COMBINATION THYMOSIN-ALPHA(1) (T-ALPHA(1)) AND LYMPHOBLASTOID INTERFERON (L-IFN) THERAPY IN CHRONIC HEPATITIS-C (CHC)
Authors: RASI G MUTCHNICK MG DIVIRGILIO D PIERIMARCHI P SINIBALDIVALLEBONA P COLELLA F GARACI E
Citation: G. Rasi et al., COMBINATION THYMOSIN-ALPHA(1) (T-ALPHA(1)) AND LYMPHOBLASTOID INTERFERON (L-IFN) THERAPY IN CHRONIC HEPATITIS-C (CHC), Gastroenterology, 108(4), 1995, pp. 1153-1153
AUTHENTIC THYMOSIN-ALPHA(1) IS PRESENT IN SERUM FOLLOWING SUBCUTANEOUS ADMINISTRATION TO HUMAN-SUBJECTS
Authors: NAYLOR PH CHAIWALA S REDDY S SIDDIQUI F NAYLOR CW SASAKI D MUTCHNICK MG
Citation: Ph. Naylor et al., AUTHENTIC THYMOSIN-ALPHA(1) IS PRESENT IN SERUM FOLLOWING SUBCUTANEOUS ADMINISTRATION TO HUMAN-SUBJECTS, The FASEB journal, 8(4), 1994, pp. 10000481-10000481
INHIBITION OF HBV-HEPG2 ANCHORAGE-INDEPENDENT GROWTH IS ENHANCED BY THE COMBINATION OF THYMOSIN ALPHA-1 AND INTERFERON-ALPHA
Authors: MOSHIER JA MUTCHNICK MG DOSESCU J MERLINE J NAYLOR PH
Citation: Ja. Moshier et al., INHIBITION OF HBV-HEPG2 ANCHORAGE-INDEPENDENT GROWTH IS ENHANCED BY THE COMBINATION OF THYMOSIN ALPHA-1 AND INTERFERON-ALPHA, Hepatology, 20(4), 1994, pp. 10000284-10000284
COMBINATION LOW-DOSE LYMPHOBLASTOID INTERFERON (L-IFN-ALPHA) AND THYMOSIN-ALPHA(1) (T-ALPHA(1)) THERAPY IN THE TREATMENT OF CHRONIC HEPATITIS-B
Authors: RASI G MUTCHNICK MG DIVIRGILIO D PIERIMARCHI P SINIBALDIVALLEBONA P COLELLA F FAVALLI C GARACI E
Citation: G. Rasi et al., COMBINATION LOW-DOSE LYMPHOBLASTOID INTERFERON (L-IFN-ALPHA) AND THYMOSIN-ALPHA(1) (T-ALPHA(1)) THERAPY IN THE TREATMENT OF CHRONIC HEPATITIS-B, Hepatology, 20(4), 1994, pp. 10000299-10000299
PROSPECTIVES ON THE TREATMENT OF CHRONIC HEPATITIS-B AND CHRONIC HEPATITIS-C WITH THYMIC PEPTIDES AND ANTIVIRAL AGENTS
Authors: MUTCHNICK MG EHRINPREIS MN KINZIE JL PELEMAN RR
Citation: Mg. Mutchnick et al., PROSPECTIVES ON THE TREATMENT OF CHRONIC HEPATITIS-B AND CHRONIC HEPATITIS-C WITH THYMIC PEPTIDES AND ANTIVIRAL AGENTS, Antiviral research, 24(2-3), 1994, pp. 245-257
Risultati: 1-25 | 26-32